This treatment is also considered for other defects with an IBD phenotype, including severe X-linked CGD (around 96% successful) and XIAP deficiency (around 82% successful) (70, 72). The gene discussed is XIAP; the disease is hyperinsulinemic hypoglycemia, familial, 4.